Quality of life in children with non-cystic-fibrosis bronchiectasis

Yasemin Gokdemir1, Ameer Hamzah, Ela Erdem

  • 1Division of Pediatric Pulmonology, Marmara University, School of Medicine, Istanbul, Turkey.

Insights

Early diagnosis and regular follow-up improve quality of life (QOL) in children with non-cystic-fibrosis bronchiectasis (non-CF BE). Symptom severity correlates with poorer pulmonary function and QOL.

Area of Science:

  • Pediatric Pulmonology
  • Quality of Life Research

Background:

  • Non-cystic-fibrosis bronchiectasis (non-CF BE) remains a significant health issue, particularly in developing nations.
  • Assessing the impact of non-CF BE on children's lives is crucial for effective management.

Purpose of the Study:

  • To evaluate health-related quality of life (HRQOL) in pediatric non-CF BE patients.
  • To identify risk factors associated with HRQOL in this population.

Main Methods:

  • Prospective study involving 42 non-CF BE patients aged 9-18 years.
  • Utilized Short-Form-36 (SF-36) and St. George's Respiratory Questionnaire (SGRQ) for HRQOL assessment.
  • Correlated HRQOL scores with demographic data, pulmonary function, CT findings, and socioeconomic status.

Main Results:

  • Significant inverse correlations found between SF-36 and SGRQ subscales, indicating poorer QOL with increased symptoms.
  • SGRQ symptom scores correlated positively with frequent antibiotic use and negatively with pulmonary function.
  • Longer regular follow-up duration showed an inverse correlation with SGRQ symptom scores.

Conclusions:

  • Early diagnosis and consistent follow-up are vital for enhancing QOL in children with non-CF BE.
  • Symptom severity and frequency directly impact pulmonary function and overall QOL.
  • Development of a disease-specific QOL questionnaire for pediatric non-CF BE is recommended.
Abstract

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
657
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
35
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K